AZD6422CLDN18.2aCD20esophageal cancers
…reen S, Broggi, MAS, Hatke AL, et al. Preclinical evaluation of AZD6422, an armored chimeric antigen receptor T cell targeting CLDN18.2…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: aCD20 ×
aCD20
This drug is selected. Its supporting articles are shown below.